Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothena Biosciences LtdfiledCriticalProthena Biosciences Ltd
Priority claimed from PCT/US2020/020704external-prioritypatent/WO2020180819A1/en
Publication of MX2021010517ApublicationCriticalpatent/MX2021010517A/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
La invención proporciona anticuerpos que se unen específicamente a tau. Los anticuerpos inhibien o retrsan las patologías asociadas a tau y el deterioro sintomático asociado.
MX2021010517A2019-03-032020-03-02Anticuerpos que reconocen tau.
MX2021010517A
(es)